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Giant aneurysms of the anterior intracranial circulation are rare, slowly progressive vascular abnormalities, often presenting with
neuro-ophthalmological symptoms before they rupture. This is a case of a 55-year-old woman with a double aneurysm of the
anterior intracranial circulation, part of which was giant, diagnosed exclusively on the basis of ocular manifestations. We also
describe successful management of the case throughout a long follow-up period.
1.Introduction
Intracranial aneurysms, most of which asymptomatic, are
estimated to be present in approximately 5% of the popu-
lation [1, 2]. The most serious complication of intracranial
aneurysms is subarachnoid hemorrhage, which results in
death in 50% of cases. Larger aneurysms are considered
to carry a higher rupture risk, especially when located in
the posterior circulation [3]. Small (<10mm) and medium
(10–25mm) aneurysms tend to rupture without previ-
ous symptomatology, whereas giant aneurysms (diameter
>25mm)haveadiﬀerentnaturalcourse,progressslowly,and
usually(in50%ofpatients)produceneurologicalsymptoms,
depending on the location, size, and the way of expansion
[4, 5].
2. Case Presentation
A 55-year-old female presented complaining of reduced
visual acuity in the left eye that had been progressing for
5 months. She had no remarkable medical history and
was not receiving any medical treatment. Visual acuity in
the Snellen chart was 20/20 in the right eye and 20/40 in
the left eye. Pupillary responses were normal in both eyes
whereas color vision, tested with the Ishihara charts, was
signiﬁcantly disturbed in the left eye. Slit lamp examination
and intraocular pressure were normal in both eyes. Dilated
fundus examination disclosed no pathology. Visual ﬁelds
examination (Humphrey 24-2 SITA standard) was normal in
the right eye and revealed a deep central scotoma in the left
eye (Figure 1). The patient refused to undergo the suggested
MRI examination, at that time.
Twenty days later, the patient returned with further
loss of vision in her left eye. Ocular examination revealed
visual acuity in the left eye 20/80 and a relatively aﬀerent
pupillary defect (RAPD). Fundus examination disclosed
partial atrophy of the left optic nerve.
Emergency MRI and consequent selective digital angiog-
raphy conﬁrmed the presence of a giant aneurysm of
28mm of diameter, arising from the supraclinoid part of
the left internal carotid and a second smaller aneurysm of
9mm diameter with a wide base near the origin of the
left ophthalmic artery (Figures 2 and 3). The patient was
referredtotheDepartmentofNeurosurgerywheresuccessful
endovascular embolism of the aneurysms was performed,
leaving the left internal carotid blood ﬂow intact. Three
months later, the patient presented with worsening of vision
in her left eye, which was assessed to 20/400. The new MRA
showed late failure of the previous embolization procedure,
due to recanalization of the aneurysm. An additional, totally
successful, embolization was performed (Figure 4).2 Case Reports in Medicine
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Figure 1: Visual ﬁelds of the patient at presentation. The RE is normal, and the LE shows a deep central scotoma (V/A 20/40).
Figure 2: Axial T1-weighted MRI revealing the giant internal
carotid aneurysm.
The patient’s symptoms gradually recessed, and, at 20
months followup, visual acuity is 20/25 with signiﬁcant
improvementofvisualﬁeldsﬁndings(Figure 5).Partialatro-
phy of the left optic nerve is a constant ﬁnding throughout
follow-up period.
3. Discussion
Giant aneurysms are most frequently located in the anterior
part of the cerebral circulation (75%) and may induce severe
pressure on one or both optic nerves, resulting in visual
ﬁeld and visual acuity disturbances [5, 6]. Diplopia due to
third nerve palsy may occur owing to either expansion of
the aneurysmal sac or rupture of the aneurysm. Intraocular
hemorrhage is a rare complication.
Supraclinoid aneurysms, arising from the internal
carotidarterydistaltotheophthalmicarteryandproximalto
Figure 3: 3-dimensional digital angiography illustrating the double
aneurysm.
the posterior communicative artery junction, tend to present
late, usually with progressive visual loss rather than rupture
[7]. Like in our case, patients typically have visual complains
and visual ﬁeld defects. Monocular visual ﬁeld defects are
most common [8].
Management of giant aneurysms is controversial. Treat-
ment options include microsurgical clipping, endovascular
treatment, and combined techniques and observation. Con-
servative treatment leads to a 60% mortality rate within 2
years from diagnosis [9].
Surgical treatment oﬀers patients immediate relief of
pressure, by deﬂating the aneurysmal sac, which is crucial
in order to avoid permanent loss of visual ability in certainCase Reports in Medicine 3
Figure 4: Digital angiography of the aneurysms after the second successful embolization.
Figure 5: Visual ﬁeld of the LE 20 months after successful embolism (V/A 20/25).
patients. On the other hand, microsurgical treatment is
related to higher rates of postoperative morbidity, depending
on patient’s age and general condition [3, 9]. A recently
published series of surgically treated giant aneurysms
reports 13% surgical mortality and 9% permanent neuro-
logical morbidity, with overall good outcome in 81% of
cases [10]. Therefore, treatment is usually individualized
[9, 11].
Coiling relieves pressure more gradually, by replacing
the volume of the aneurysm. In a series of 321 unrup-
turedaneurysmsthatunderwentendovascularembolization,
overall mortality was estimated to be 1.7%. Total occlusion
of the aneurysm was accomplished in 68.5% of patients
and subtotal in 27.8% [12]. Technical failure appeared
to be the most signiﬁcant complication of endovascular
treatment,leadingtosecondarytreatmentin3.2%ofcases.A
recent meta-analysis of endovascular treatment of intracra-
nial unruptured aneurysms estimated that retreatment is
necessary in 9.1% of cases [13].
In our case, visual function, as expressed by visual
acuity and visual ﬁelds measurements, showed dramatic
improvement following successful retreatment. This favor-
able outcome is consistent with the literature showing
the importance of prompt treatment. Best results, with
improvement of vision, are obtained when patients are
operated within a few months from the ﬁrst symptoms
[5].
Giant cerebral aneurysms, though rare, can be a cause
of mortality and morbidity. Since they give no intense
early symptomatology, high clinical suspicion is required in
cases of inexplicable reduction in visual acuity or atypical
symptoms. Prompt recognition and treatment is mandatory
to preserve patient’s life and visual function.
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